SCHEMBL23861481

SCHEMBL23861481

Oc1ccc2ccc(O)c(C(c3ccccc3)(c3ccccc3)c3c(O)ccc4ccc(O)cc34)c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 4/20 0.41
▸ ESR2 Q92731 4/20 0.41
▸ CYP1A2 P05177 3/20 0.40
▸ CYP2D6 P10635 2/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ HSD17B1 P14061 1/20 0.40
▸ CYP2B6 P20813 1/20 0.40
▸ HSD17B2 P37059 1/20 0.40
▸ CDK4 P11802 4/20 0.38
▸ CCND1 P24385 4/20 0.38
▸ MCL1 Q07820 1/20 0.38
▸ PTPN22 Q9Y2R2 1/20 0.37
▸ TRPV1 Q8NER1 1/20 0.37
▸ MPL P40238 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ G6PD P11413 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23861405 0.89 MEN1 (0.43) TRPV1MPLKDM4EMEN1POLB
SCHEMBL23861629 0.88 ESR2 (0.46) ESR1ESR2CYP1A2CYP2D6CYP2C9
SCHEMBL23861627 0.84 PTPN22 (0.50) CYP1A2CYP2D6CYP2C9CYP2C19PTPN22
SCHEMBL23861444 0.83 ESR1 (0.50) ESR1ESR2CYP1A2CYP2D6CYP2C9
SCHEMBL23861408 0.78 ERN1 (0.44) ESR1ESR2CYP1A2CYP2D6CYP2C9
SCHEMBL23082042 0.75 ESR1 (0.48) ESR1ESR2CYP1A2CYP2D6CYP2C9
SCHEMBL29493119 0.74 LMNA (0.50) ESR1ESR2CYP1A2CYP2C9MCL1
SCHEMBL2186567 0.74 LMNA (0.50) ESR1ESR2CYP1A2CYP2C9MCL1
SCHEMBL23861567 0.74 ESR1 (0.41) ESR1ESR2CYP2C9CYP3A4HSD17B2
SCHEMBL9618414 0.74 ESR1 (0.47) ESR1ESR2CYP2C9CYP3A4HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11130724-B2 Compound, resin, composition, resist pattern formation method, and circuit pattern formation method RER1, NBAS, INTS9 ESR1 713/4885ESR2 1033/4885CYP1A2 2085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback